Pharma package revisions embed a European solidarity mechanism, says Belgian MEP Ries

EURACTIV - Patients with rare diseases will be clear beneficiaries of the European Parliament's vote on the revised pharmaceutical legislation, says Belgian MEP Frédérique Ries. The pharma package revisions will also embed a European solidarity mechanism, capitalising on European added value. Read more

Belgian MEP Frédérique Ries (Courtesy of the office of Belgian MEP Ries)